Intelligent Bio Solutions Inc.

INBS

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001725430

SEC filings (opens in a new tab)

No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Intelligent Bio Solutions Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of INBS: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	10	9	−1
Shares	344.2K	241.8K	−102.3K (−29.7%)
Value	$868.0K	$347.0K	−$521.0K (−60.0%)

New holders (2)

Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to INBS in Q4 2021
Institution	Shares	Value	% of portfolio
Jane Street Group, LLC	25,184	$36.0K	0.00%
Two Sigma Securities, LLC	16,723	$24.0K	0.00%

Sold out (3)

Institutions that held Intelligent Bio Solutions Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of INBS in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Geode Capital Management, LLC	108,353	$273.0K
Bank of New York Mellon Corp	31,140	$78.0K
Morgan Stanley	300	$1.00K